COMPANY
ADORA Life Science
From press sources: Developing matrix restoration therapeutics based on repurposing PSGAG, a chondroitin sulfate derived biopolymer with more than 40 years of veterinary use as a disease-modifying antiarthritic drug. Products under development are for treating arthritis pain, inflammation, and diabetic skin conditions. Source